Quantitative Evaluation of Chinese Herb Medicine in the Treatment of Sialorrhea and Frequent Nighttime Urination in Patients with Parkinson’s Disease
Aims. To evaluate the efficacy of Lian-Se formula (LSF), one Chinese herb formulation for treating sialorrhea and frequent overnight urination in patients with Parkinson’s disease (PD). Methods. 96 PD patients suffering from sialorrhea and/or frequent nighttime urination were divided into two groups...
Gespeichert in:
Veröffentlicht in: | Evidence-based complementary and alternative medicine 2017-01, Vol.2017 (2017), p.1-6 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6 |
---|---|
container_issue | 2017 |
container_start_page | 1 |
container_title | Evidence-based complementary and alternative medicine |
container_volume | 2017 |
creator | Liu, Te Gao, Penglin Liao, Weilong Jiang, Wenfei Wang, Dandan Sun, Chuanhe Pan, Weidong |
description | Aims. To evaluate the efficacy of Lian-Se formula (LSF), one Chinese herb formulation for treating sialorrhea and frequent overnight urination in patients with Parkinson’s disease (PD). Methods. 96 PD patients suffering from sialorrhea and/or frequent nighttime urination were divided into two groups: an LSF group (n = 48) treated with LSF for 6 weeks and a placebo group (n = 48) treated with a placebo formula whose appearance and taste were the same as LSF for 6 weeks. All patients were treated by standard antiparkinsonism medicine according to the PD guideline of China. The changes of the quantity of saliva (QS) (mL), frequency of nighttime urination (FNU) and early sleep activity (ESA), and nocturnal activity (NA) by analyzing actigraphic records as the primary results and the total score of unified Parkinson’s disease rating scale (UPDRS) and the Epworth Sleepiness Scale (ESS) as the secondary results were used to evaluate the clinical efficacy in both groups. Results. There were no significant differences in the baseline values of QS, FNU, NA, ESA, UPDRS total score, and ESS between the two groups. At the end of week 6, the QS, FNU, NA, and ESA in the LSF group showed superior results to those of the placebo group with no differences in the total UPDRS score between the two groups during the investigation. The ESS was significantly improved at the end of week 6 compared with the baseline and the placebo group. Laboratory test results indicated there were no side effects in either group. Conclusion. The findings of LSF treatment have clear clinical effects in patients with sialorrhea and frequent overnight urination. LSF thus appears to be a potential choice as an additional drug that can improve the sialorrhea and frequent overnight urination symptoms of PD patients. |
doi_str_mv | 10.1155/2017/3045260 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5412142</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A556064201</galeid><sourcerecordid>A556064201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-d93320d197972f3e961121409aaebf81bcce834c528ce247c0fb7d3cf10dd863</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEoh9w44wscUGCpf5KHF8qVUtLkcqXWCRuluNMNi5Zu9jOVr3xLxB_j1-Co12WwomTZzSP35nRvEXxiOAXhJTlEcVEHDHMS1rhO8U-EZzMOK3ru7tYfN4rDmK8xJhKIcT9Yo_WvOYlZvvF9w-jdskmnewa0OlaD2MOvUO-Q_PeOoiAziE06A201uQcWYdSD2gRQKcVuDSRH60efAg9aKRdi84CfB2n0lu77FOyK0CfgnUb4fz_fY5yOaJrm_qchS_WRe9-fvsR0UsbQUd4UNzr9BDh4fY9LBZnp4v5-ezi3avX85OLmeFSplkrGaO4JVJIQTsGsiKEEo6l1tB0NWmMgZpxU9LaAOXC4K4RLTMdwW1bV-ywON7IXo3NClqTpwp6UFfBrnS4UV5b9XfF2V4t_VqVfOpDs8DTrUDweeeY1MpGA8OgHfgxKlLLqpaCS5HRJ_-gl34MLm83UYzLfK5b1FIPoKzrfO5rJlF1UpYVrng-eKaebygTfIwBut3IBKvJFmqyhdraIuOPb6-5g3_7IAPPNkA-eauv7X_KQWag039oUjJOJfsFw8XMIQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1893491747</pqid></control><display><type>article</type><title>Quantitative Evaluation of Chinese Herb Medicine in the Treatment of Sialorrhea and Frequent Nighttime Urination in Patients with Parkinson’s Disease</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Liu, Te ; Gao, Penglin ; Liao, Weilong ; Jiang, Wenfei ; Wang, Dandan ; Sun, Chuanhe ; Pan, Weidong</creator><contributor>Wattanathorn, Jintanaporn</contributor><creatorcontrib>Liu, Te ; Gao, Penglin ; Liao, Weilong ; Jiang, Wenfei ; Wang, Dandan ; Sun, Chuanhe ; Pan, Weidong ; Wattanathorn, Jintanaporn</creatorcontrib><description>Aims. To evaluate the efficacy of Lian-Se formula (LSF), one Chinese herb formulation for treating sialorrhea and frequent overnight urination in patients with Parkinson’s disease (PD). Methods. 96 PD patients suffering from sialorrhea and/or frequent nighttime urination were divided into two groups: an LSF group (n = 48) treated with LSF for 6 weeks and a placebo group (n = 48) treated with a placebo formula whose appearance and taste were the same as LSF for 6 weeks. All patients were treated by standard antiparkinsonism medicine according to the PD guideline of China. The changes of the quantity of saliva (QS) (mL), frequency of nighttime urination (FNU) and early sleep activity (ESA), and nocturnal activity (NA) by analyzing actigraphic records as the primary results and the total score of unified Parkinson’s disease rating scale (UPDRS) and the Epworth Sleepiness Scale (ESS) as the secondary results were used to evaluate the clinical efficacy in both groups. Results. There were no significant differences in the baseline values of QS, FNU, NA, ESA, UPDRS total score, and ESS between the two groups. At the end of week 6, the QS, FNU, NA, and ESA in the LSF group showed superior results to those of the placebo group with no differences in the total UPDRS score between the two groups during the investigation. The ESS was significantly improved at the end of week 6 compared with the baseline and the placebo group. Laboratory test results indicated there were no side effects in either group. Conclusion. The findings of LSF treatment have clear clinical effects in patients with sialorrhea and frequent overnight urination. LSF thus appears to be a potential choice as an additional drug that can improve the sialorrhea and frequent overnight urination symptoms of PD patients.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2017/3045260</identifier><identifier>PMID: 28484503</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Angina pectoris ; Care and treatment ; Chinese medicine ; Chronic obstructive pulmonary disease ; Health aspects ; Herbs ; Hospitals ; Neurology ; Parkinson's disease ; Patients ; Quality of life ; Sleep ; Urination ; Urology</subject><ispartof>Evidence-based complementary and alternative medicine, 2017-01, Vol.2017 (2017), p.1-6</ispartof><rights>Copyright © 2017 Chuanhe Sun et al.</rights><rights>COPYRIGHT 2017 John Wiley & Sons, Inc.</rights><rights>Copyright © 2017 Chuanhe Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2017 Chuanhe Sun et al. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-d93320d197972f3e961121409aaebf81bcce834c528ce247c0fb7d3cf10dd863</citedby><cites>FETCH-LOGICAL-c499t-d93320d197972f3e961121409aaebf81bcce834c528ce247c0fb7d3cf10dd863</cites><orcidid>0000-0003-1514-9548 ; 0000-0002-0380-4210</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412142/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412142/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28484503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Wattanathorn, Jintanaporn</contributor><creatorcontrib>Liu, Te</creatorcontrib><creatorcontrib>Gao, Penglin</creatorcontrib><creatorcontrib>Liao, Weilong</creatorcontrib><creatorcontrib>Jiang, Wenfei</creatorcontrib><creatorcontrib>Wang, Dandan</creatorcontrib><creatorcontrib>Sun, Chuanhe</creatorcontrib><creatorcontrib>Pan, Weidong</creatorcontrib><title>Quantitative Evaluation of Chinese Herb Medicine in the Treatment of Sialorrhea and Frequent Nighttime Urination in Patients with Parkinson’s Disease</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>Aims. To evaluate the efficacy of Lian-Se formula (LSF), one Chinese herb formulation for treating sialorrhea and frequent overnight urination in patients with Parkinson’s disease (PD). Methods. 96 PD patients suffering from sialorrhea and/or frequent nighttime urination were divided into two groups: an LSF group (n = 48) treated with LSF for 6 weeks and a placebo group (n = 48) treated with a placebo formula whose appearance and taste were the same as LSF for 6 weeks. All patients were treated by standard antiparkinsonism medicine according to the PD guideline of China. The changes of the quantity of saliva (QS) (mL), frequency of nighttime urination (FNU) and early sleep activity (ESA), and nocturnal activity (NA) by analyzing actigraphic records as the primary results and the total score of unified Parkinson’s disease rating scale (UPDRS) and the Epworth Sleepiness Scale (ESS) as the secondary results were used to evaluate the clinical efficacy in both groups. Results. There were no significant differences in the baseline values of QS, FNU, NA, ESA, UPDRS total score, and ESS between the two groups. At the end of week 6, the QS, FNU, NA, and ESA in the LSF group showed superior results to those of the placebo group with no differences in the total UPDRS score between the two groups during the investigation. The ESS was significantly improved at the end of week 6 compared with the baseline and the placebo group. Laboratory test results indicated there were no side effects in either group. Conclusion. The findings of LSF treatment have clear clinical effects in patients with sialorrhea and frequent overnight urination. LSF thus appears to be a potential choice as an additional drug that can improve the sialorrhea and frequent overnight urination symptoms of PD patients.</description><subject>Angina pectoris</subject><subject>Care and treatment</subject><subject>Chinese medicine</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Health aspects</subject><subject>Herbs</subject><subject>Hospitals</subject><subject>Neurology</subject><subject>Parkinson's disease</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Sleep</subject><subject>Urination</subject><subject>Urology</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkk1v1DAQhiMEoh9w44wscUGCpf5KHF8qVUtLkcqXWCRuluNMNi5Zu9jOVr3xLxB_j1-Co12WwomTZzSP35nRvEXxiOAXhJTlEcVEHDHMS1rhO8U-EZzMOK3ru7tYfN4rDmK8xJhKIcT9Yo_WvOYlZvvF9w-jdskmnewa0OlaD2MOvUO-Q_PeOoiAziE06A201uQcWYdSD2gRQKcVuDSRH60efAg9aKRdi84CfB2n0lu77FOyK0CfgnUb4fz_fY5yOaJrm_qchS_WRe9-fvsR0UsbQUd4UNzr9BDh4fY9LBZnp4v5-ezi3avX85OLmeFSplkrGaO4JVJIQTsGsiKEEo6l1tB0NWmMgZpxU9LaAOXC4K4RLTMdwW1bV-ywON7IXo3NClqTpwp6UFfBrnS4UV5b9XfF2V4t_VqVfOpDs8DTrUDweeeY1MpGA8OgHfgxKlLLqpaCS5HRJ_-gl34MLm83UYzLfK5b1FIPoKzrfO5rJlF1UpYVrng-eKaebygTfIwBut3IBKvJFmqyhdraIuOPb6-5g3_7IAPPNkA-eauv7X_KQWag039oUjJOJfsFw8XMIQ</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Liu, Te</creator><creator>Gao, Penglin</creator><creator>Liao, Weilong</creator><creator>Jiang, Wenfei</creator><creator>Wang, Dandan</creator><creator>Sun, Chuanhe</creator><creator>Pan, Weidong</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1514-9548</orcidid><orcidid>https://orcid.org/0000-0002-0380-4210</orcidid></search><sort><creationdate>20170101</creationdate><title>Quantitative Evaluation of Chinese Herb Medicine in the Treatment of Sialorrhea and Frequent Nighttime Urination in Patients with Parkinson’s Disease</title><author>Liu, Te ; Gao, Penglin ; Liao, Weilong ; Jiang, Wenfei ; Wang, Dandan ; Sun, Chuanhe ; Pan, Weidong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-d93320d197972f3e961121409aaebf81bcce834c528ce247c0fb7d3cf10dd863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Angina pectoris</topic><topic>Care and treatment</topic><topic>Chinese medicine</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Health aspects</topic><topic>Herbs</topic><topic>Hospitals</topic><topic>Neurology</topic><topic>Parkinson's disease</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Sleep</topic><topic>Urination</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Te</creatorcontrib><creatorcontrib>Gao, Penglin</creatorcontrib><creatorcontrib>Liao, Weilong</creatorcontrib><creatorcontrib>Jiang, Wenfei</creatorcontrib><creatorcontrib>Wang, Dandan</creatorcontrib><creatorcontrib>Sun, Chuanhe</creatorcontrib><creatorcontrib>Pan, Weidong</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Te</au><au>Gao, Penglin</au><au>Liao, Weilong</au><au>Jiang, Wenfei</au><au>Wang, Dandan</au><au>Sun, Chuanhe</au><au>Pan, Weidong</au><au>Wattanathorn, Jintanaporn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantitative Evaluation of Chinese Herb Medicine in the Treatment of Sialorrhea and Frequent Nighttime Urination in Patients with Parkinson’s Disease</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>2017</volume><issue>2017</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Aims. To evaluate the efficacy of Lian-Se formula (LSF), one Chinese herb formulation for treating sialorrhea and frequent overnight urination in patients with Parkinson’s disease (PD). Methods. 96 PD patients suffering from sialorrhea and/or frequent nighttime urination were divided into two groups: an LSF group (n = 48) treated with LSF for 6 weeks and a placebo group (n = 48) treated with a placebo formula whose appearance and taste were the same as LSF for 6 weeks. All patients were treated by standard antiparkinsonism medicine according to the PD guideline of China. The changes of the quantity of saliva (QS) (mL), frequency of nighttime urination (FNU) and early sleep activity (ESA), and nocturnal activity (NA) by analyzing actigraphic records as the primary results and the total score of unified Parkinson’s disease rating scale (UPDRS) and the Epworth Sleepiness Scale (ESS) as the secondary results were used to evaluate the clinical efficacy in both groups. Results. There were no significant differences in the baseline values of QS, FNU, NA, ESA, UPDRS total score, and ESS between the two groups. At the end of week 6, the QS, FNU, NA, and ESA in the LSF group showed superior results to those of the placebo group with no differences in the total UPDRS score between the two groups during the investigation. The ESS was significantly improved at the end of week 6 compared with the baseline and the placebo group. Laboratory test results indicated there were no side effects in either group. Conclusion. The findings of LSF treatment have clear clinical effects in patients with sialorrhea and frequent overnight urination. LSF thus appears to be a potential choice as an additional drug that can improve the sialorrhea and frequent overnight urination symptoms of PD patients.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>28484503</pmid><doi>10.1155/2017/3045260</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-1514-9548</orcidid><orcidid>https://orcid.org/0000-0002-0380-4210</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1741-427X |
ispartof | Evidence-based complementary and alternative medicine, 2017-01, Vol.2017 (2017), p.1-6 |
issn | 1741-427X 1741-4288 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5412142 |
source | PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection |
subjects | Angina pectoris Care and treatment Chinese medicine Chronic obstructive pulmonary disease Health aspects Herbs Hospitals Neurology Parkinson's disease Patients Quality of life Sleep Urination Urology |
title | Quantitative Evaluation of Chinese Herb Medicine in the Treatment of Sialorrhea and Frequent Nighttime Urination in Patients with Parkinson’s Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T12%3A42%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantitative%20Evaluation%20of%20Chinese%20Herb%20Medicine%20in%20the%20Treatment%20of%20Sialorrhea%20and%20Frequent%20Nighttime%20Urination%20in%20Patients%20with%20Parkinson%E2%80%99s%20Disease&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Liu,%20Te&rft.date=2017-01-01&rft.volume=2017&rft.issue=2017&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2017/3045260&rft_dat=%3Cgale_pubme%3EA556064201%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1893491747&rft_id=info:pmid/28484503&rft_galeid=A556064201&rfr_iscdi=true |